|
SUPT7L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.543000E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.608300E-04 |
| Normal-vs-Stage2 |
3.603600E-01 |
| Normal-vs-Stage3 |
8.562200E-02 |
| Normal-vs-Stage4 |
2.413400E-01 |
| Stage1-vs-Stage2 |
3.048800E-01 |
| Stage1-vs-Stage3 |
2.890200E-01 |
| Stage1-vs-Stage4 |
1.904800E-01 |
| Stage2-vs-Stage3 |
8.067000E-01 |
| Stage2-vs-Stage4 |
9.629200E-01 |
| Stage3-vs-Stage4 |
7.210400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.132200E-02 |
| Normal-vs-AfricanAmerican |
6.916400E-02 |
| Normal-vs-Asian |
3.54560000248583E-08 |
| Caucasian-vs-AfricanAmerican |
4.842000E-01 |
| Caucasian-vs-Asian |
1.960280E-03 |
| AfricanAmerican-vs-Asian |
2.061700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.563770E-01 |
| Normal-vs-Female |
1.5800999999982E-05 |
| Male-vs-Female |
3.645500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.513800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.630900E-04 |
| Normal-vs-Age(61-80Yrs) |
5.788000E-02 |
| Normal-vs-Age(81-100Yrs) |
2.743600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.875760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.252400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.759400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.305980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.367200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.776400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.958000E-03 |
| Normal-vs-Grade 2 |
6.787700E-04 |
| Normal-vs-Grade 3 |
3.133900E-02 |
| Normal-vs-Grade 4 |
8.223400E-01 |
| Grade 1-vs-Grade 2 |
1.051050E-01 |
| Grade 1-vs-Grade 3 |
3.194400E-02 |
| Grade 1-vs-Grade 4 |
4.179000E-03 |
| Grade 2-vs-Grade 3 |
2.087600E-01 |
| Grade 2-vs-Grade 4 |
2.350300E-02 |
| Grade 3-vs-Grade 4 |
1.633970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.79830000000192E-05 |
| Normal-vs-ccB subtype |
3.065600E-01 |
| ccA subtype-vs-ccB subtype |
5.235800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.296800E-03 |
| Normal-vs-N1 |
5.521200E-01 |
| N0-vs-N1 |
6.969600E-01 |
|
|
